International study of the prevalence and factors associated with insomnia in the general population. 2021

Eva Aernout, and Imane Benradia, and Jean-Baptiste Hazo, and Aminata Sy, and Françoise Askevis-Leherpeux, and Déborah Sebbane, and Jean-Luc Roelandt
EPSM Lille Métropole, Centre Collaborateur de l'Organisation Mondiale de la Santé pour la recherche et la formation en santé mentale, 59260 Lille-Hellemmes, France. Electronic address: eaernout@epsm-lm.fr.

Insomnia is a public health problem with many repercussions. It affects a significant proportion of the general population worldwide, but the estimated prevalences in different countries are difficult to compare due to the use of heterogeneous methodologies. The objectives of the study were to compare the prevalence of insomnia in the general population in different sites around the world and to identify sociodemographic and mental health associated factors, using the same tool and within a single study. This multicenter cross-sectional study is based on the Mental Health in the General Population survey (MHPG). It included several sites in France and 12 countries around the world with a representative sampling of the general population. The prevalence of short-term insomnia disorder was estimated by the occurrence within one month of at least one symptom, at a minimum frequency of three per week, with repercussions on everyday life. Out of the 57,298 participants, 11.3% had a diagnosis of short-term insomnia disorder, with significant differences in prevalence between sites, ranging from 2.3% to 25.5%. Insomnia was significantly related to having mood disorders, anxiety disorders, substance use disorders and psychotic disorders. Insomnia was also more common among women, older adults, working participants and those who practice a religion. The prevalence of insomnia was highly variable between sites, but the predictors appeared to be the same everywhere. Insomnia seemed to be more related to the presence of mood and anxiety disorders than a site-specific effect and thus may be a good indicator of mental health.

UI MeSH Term Description Entries
D007319 Sleep Initiation and Maintenance Disorders Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition. Disorders of Initiating and Maintaining Sleep,Insomnia,Sleeplessness,Chronic Insomnia,DIMS (Disorders of Initiating and Maintaining Sleep),Early Awakening,Insomnia Disorder,Nonorganic Insomnia,Primary Insomnia,Psychophysiological Insomnia,Rebound Insomnia,Secondary Insomnia,Sleep Initiation Dysfunction,Transient Insomnia,Awakening, Early,Dysfunction, Sleep Initiation,Dysfunctions, Sleep Initiation,Insomnia Disorders,Insomnia, Chronic,Insomnia, Nonorganic,Insomnia, Primary,Insomnia, Psychophysiological,Insomnia, Rebound,Insomnia, Secondary,Insomnia, Transient,Insomnias,Sleep Initiation Dysfunctions
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D005260 Female Females
D005602 France A country in western Europe bordered by the Atlantic Ocean, the English Channel, the Mediterranean Sea, and the countries of Belgium, Germany, Italy, Spain, Switzerland, the principalities of Andorra and Monaco, and by the duchy of Luxembourg. Its capital is Paris. Corsica,Saint Pierre and Miquelon,Miquelon and Saint Pierre,Miquelon and St. Pierre,St. Pierre and Miquelon
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001008 Anxiety Disorders Persistent and disabling ANXIETY. Anxiety Neuroses,Anxiety States, Neurotic,Neuroses, Anxiety,Anxiety Disorder,Anxiety State, Neurotic,Disorder, Anxiety,Disorders, Anxiety,Neurotic Anxiety State,Neurotic Anxiety States,State, Neurotic Anxiety,States, Neurotic Anxiety
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences

Related Publications

Eva Aernout, and Imane Benradia, and Jean-Baptiste Hazo, and Aminata Sy, and Françoise Askevis-Leherpeux, and Déborah Sebbane, and Jean-Luc Roelandt
February 2021, BMC psychiatry,
Eva Aernout, and Imane Benradia, and Jean-Baptiste Hazo, and Aminata Sy, and Françoise Askevis-Leherpeux, and Déborah Sebbane, and Jean-Luc Roelandt
August 2023, Cureus,
Eva Aernout, and Imane Benradia, and Jean-Baptiste Hazo, and Aminata Sy, and Françoise Askevis-Leherpeux, and Déborah Sebbane, and Jean-Luc Roelandt
November 2003, Sleep medicine,
Eva Aernout, and Imane Benradia, and Jean-Baptiste Hazo, and Aminata Sy, and Françoise Askevis-Leherpeux, and Déborah Sebbane, and Jean-Luc Roelandt
December 2013, Revue neurologique,
Eva Aernout, and Imane Benradia, and Jean-Baptiste Hazo, and Aminata Sy, and Françoise Askevis-Leherpeux, and Déborah Sebbane, and Jean-Luc Roelandt
August 1992, Archives of internal medicine,
Eva Aernout, and Imane Benradia, and Jean-Baptiste Hazo, and Aminata Sy, and Françoise Askevis-Leherpeux, and Déborah Sebbane, and Jean-Luc Roelandt
July 2012, Journal of psychosomatic research,
Eva Aernout, and Imane Benradia, and Jean-Baptiste Hazo, and Aminata Sy, and Françoise Askevis-Leherpeux, and Déborah Sebbane, and Jean-Luc Roelandt
December 2006, Cephalalgia : an international journal of headache,
Eva Aernout, and Imane Benradia, and Jean-Baptiste Hazo, and Aminata Sy, and Françoise Askevis-Leherpeux, and Déborah Sebbane, and Jean-Luc Roelandt
June 2020, BMC public health,
Eva Aernout, and Imane Benradia, and Jean-Baptiste Hazo, and Aminata Sy, and Françoise Askevis-Leherpeux, and Déborah Sebbane, and Jean-Luc Roelandt
March 2017, International journal of cardiology,
Eva Aernout, and Imane Benradia, and Jean-Baptiste Hazo, and Aminata Sy, and Françoise Askevis-Leherpeux, and Déborah Sebbane, and Jean-Luc Roelandt
February 2010, Journal of the Formosan Medical Association = Taiwan yi zhi,
Copied contents to your clipboard!